» Articles » PMID: 28497350

Synovial Cellular and Molecular Markers in Rheumatoid Arthritis

Overview
Publisher Springer
Date 2017 May 13
PMID 28497350
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

The profound alterations in the structure, cellular composition, and function of synovial tissue in rheumatoid arthritis (RA) are the basis for the persistent inflammation and cumulative joint destruction that are hallmarks of this disease. In RA, the synovium develops characteristics of a tertiary lymphoid organ, with extensive infiltration of lymphocytes and myeloid cells. Concurrently, the fibroblast-like synoviocytes undergo massive hyperplasia and acquire a tissue-invasive phenotype. In this review, we summarize key components of these processes, focusing on recently-described roles of selected molecular markers of these cellular components of RA synovitis.

Citing Articles

Prodrug Nanomedicine for Synovium Targeted Therapy of Inflammatory Arthritis: Insights from Animal Model and Human Synovial Joint Fluid.

Nosrati Z, Chen Y, Bergamo M, Rodriguez-Rodriguez C, Chan J, Shojania K Adv Healthc Mater. 2024; 13(30):e2401936.

PMID: 39380387 PMC: 11616258. DOI: 10.1002/adhm.202401936.


Dihydroartemisinin Regulated the MMP-Mediated Cellular Microenvironment to Alleviate Rheumatoid Arthritis.

Guo Q, Wang Q, Chen J, Zhao M, Lu T, Guo Z Research (Wash D C). 2024; 7:0459.

PMID: 39257420 PMC: 11385568. DOI: 10.34133/research.0459.


Ferroptosis in Arthritis: Driver of the Disease or Therapeutic Option?.

Bieri S, Moller B, Amsler J Int J Mol Sci. 2024; 25(15).

PMID: 39125782 PMC: 11311315. DOI: 10.3390/ijms25158212.


Surface saturation of drug-loaded hollow manganese dioxide nanoparticles with human serum albumin for treating rheumatoid arthritis.

Jia M, Ren W, Wang M, Liu Y, Wang C, Zhang Z Drug Deliv. 2024; 31(1):2380538.

PMID: 39044468 PMC: 11271085. DOI: 10.1080/10717544.2024.2380538.


Crucial Roles of RSAD2/viperin in Immunomodulation, Mitochondrial Metabolism and Autoimmune Diseases.

Chen S, Ye J, Lin Y, Chen W, Huang S, Yang Q Inflammation. 2024; .

PMID: 38909344 DOI: 10.1007/s10753-024-02076-5.


References
1.
Schellekens G, de Jong B, van den Hoogen F, van de Putte L, van Venrooij W . Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998; 101(1):273-81. PMC: 508564. DOI: 10.1172/JCI1316. View

2.
Fonseca J, Edwards J, Blades S, Goulding N . Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments. Arthritis Rheum. 2002; 46(5):1210-6. DOI: 10.1002/art.10207. View

3.
Ramprasad M, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D . Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1996; 93(25):14833-8. PMC: 26222. DOI: 10.1073/pnas.93.25.14833. View

4.
Koch A, Polverini P, Kunkel S, Harlow L, DiPietro L, Elner V . Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992; 258(5089):1798-801. DOI: 10.1126/science.1281554. View

5.
Qin S, Wang F, Zhou M, Ding W, Chen L, Lu Y . Immunolocalization of membrane-type 1 MMP in human rheumatoid synovium tissues. Int J Clin Exp Pathol. 2015; 8(8):9286-92. PMC: 4583910. View